Cargando…

Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD

INTRODUCTION: Alveolar macrophages (AMs) are equipped with innate immune receptors such as toll-like receptor 2 (TLR2) and toll-like receptor 4 (TLR4). In primary bronchial epithelial cells, exposure of toll-like receptor (TLR) ligands or tumor necrosis factor-alpha (TNF-α) increased TLR2 mRNA expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Jie, von Schéele, Ida, Billing, Bo, Dahlén, Barbro, Lantz, Ann-Sofie, Larsson, Kjell, Palmberg, Lena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876676/ https://www.ncbi.nlm.nih.gov/pubmed/27274225 http://dx.doi.org/10.2147/COPD.S102668

Ejemplares similares

Dental Health in Smokers with and without COPD
por: Bergström, Jan, et al.
Publicado: (2013)

Adhesion molecules in subjects with COPD and healthy non-smokers: a cross sectional parallel group study
por: Blidberg, Kristin, et al.
Publicado: (2013)

Compartment differences of inflammatory activity in chronic obstructive pulmonary disease
por: Ji, Jie, et al.
Publicado: (2014)

Interactions between alveolar epithelial cells and neutrophils under pro-inflammatory conditions
por: von Schéele, Ida, et al.
Publicado: (2014)

Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways
por: Levänen, Bettina, et al.
Publicado: (2016)

Extracellular cadmium in the bronchoalveolar space of long-term tobacco smokers with and without COPD and its association with inflammation
por: Sundblad, Britt-Marie, et al.
Publicado: (2016)

Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients
por: Droemann, Daniel, et al.
Publicado: (2005)

Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction
por: Lazarinis, Nikolaos, et al.
Publicado: (2014)

Biomarkers, Clinical Course, and Individual Needs in COPD Patients in Primary Care: The Study Protocol of the Stockholm COPD Inflammation Cohort (SCOPIC)
por: Lundh, Lena, et al.
Publicado: (2022)

Cholinergic mechanisms in an organic dust model simulating an acute exacerbation in patients with COPD
por: Palmberg, Lena, et al.
Publicado: (2018)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
por: Belchamber, Kylie BR, et al.
Publicado: (2018)

Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate
por: Provost, Karin A., et al.
Publicado: (2019)

Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms
por: Berenson, Charles S., et al.
Publicado: (2015)

The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages
por: Lea, Simon R, et al.
Publicado: (2018)

Daily Exposure to Dust Alters Innate Immunity
por: Sahlander, Karin, et al.
Publicado: (2012)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study
por: Ställberg, Björn, et al.
Publicado: (2009)

Budesonide/formoterol combination in COPD: a US perspective
por: Sharafkhaneh, Amir, et al.
Publicado: (2010)

Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

Apoptosis inhibitor of macrophage (AIM) expression in alveolar macrophages in COPD
por: Kojima, Jun, et al.
Publicado: (2013)

Cadmium in tobacco smokers: a neglected link to lung disease?
por: Ganguly, Koustav, et al.
Publicado: (2018)

Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust
por: Ivanov, Stefan, et al.
Publicado: (2005)

The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly
por: Guo, Min, et al.
Publicado: (2022)

Physiological and biological characterization of smokers with and without COPD
por: Chaudhary, Nveed, et al.
Publicado: (2018)

Disparate oxidant gene expression of airway epithelium compared to alveolar macrophages in smokers
por: Carolan, Brendan J, et al.
Publicado: (2009)

Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi
por: Khalaf, Rana M., et al.
Publicado: (2017)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
por: Calverley, Peter M, et al.
Publicado: (2016)

Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis
por: Calabrese, Cecilia, et al.
Publicado: (2018)

Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis
por: Tang, Bin, et al.
Publicado: (2019)

Retracted: The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Symptomatic smokers without COPD have physiological changes heralding the development of COPD
por: Bazzan, Erica, et al.
Publicado: (2022)

Characterization of throat microbial flora in smokers with or without COPD
por: Diao, Wenqi, et al.
Publicado: (2017)

Corticosteroid effects on COPD alveolar macrophages: Dependency on cell culture methodology
por: Higham, Andrew, et al.
Publicado: (2014)

Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study
por: Ferguson, Gary T., et al.
Publicado: (2018)

Characterization, localization and comparison of c-Kit+ lung cells in never smokers and smokers with and without COPD
por: López-Giraldo, Alejandra, et al.
Publicado: (2018)

Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes
por: Juarez, Esmeralda, et al.
Publicado: (2010)

Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016)

Trabecular bone score in active or former smokers with and without COPD
por: González, Jessica, et al.
Publicado: (2019)

Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study
por: Zhang, Jing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fd67ffvgk97cb5ifdig97i61aj